USNU has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
USNU has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Elite Health Systems's enterprise value is $14.57 Mil. Elite Health Systems's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was $-1.62 Mil. Therefore, Elite Health Systems's EV-to-EBITDA for today is -8.97.
The historical rank and industry rank for Elite Health Systems's EV-to-EBITDA or its related term are showing as below:
During the past 13 years, the highest EV-to-EBITDA of Elite Health Systems was 5.53. The lowest was -24.77. And the median was 0.90.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2025-05-23), Elite Health Systems's stock price is $0.89. Elite Health Systems's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was $-0.121. Therefore, Elite Health Systems's PE Ratio (TTM) for today is At Loss.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
The historical data trend for Elite Health Systems's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Elite Health Systems Annual Data | |||||||||||||||||||||
Trend | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | |||||||||||
EV-to-EBITDA | Get a 7-Day Free Trial |
![]() |
![]() |
-0.29 | -0.26 | 0.29 | -4.78 | -6.76 |
Elite Health Systems Quarterly Data | ||||||||||||||||||||
Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | Mar25 | |
EV-to-EBITDA | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
-6.45 | -5.08 | -4.50 | -6.76 | -8.53 |
For the Medical Care Facilities subindustry, Elite Health Systems's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, Elite Health Systems's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Elite Health Systems's EV-to-EBITDA falls into.
Elite Health Systems's EV-to-EBITDA for today is calculated as:
EV-to-EBITDA | = | Enterprise Value (Today) | / | EBITDA (TTM) |
= | 14.566 | / | -1.623 | |
= | -8.97 |
Elite Health Systems's current Enterprise Value is $14.57 Mil.
Elite Health Systems's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.62 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Elite Health Systems (OTCPK:USNU) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Elite Health Systems's PE Ratio (TTM) for today is calculated as:
PE Ratio (TTM) | = | Share Price (Today) | / | Earnings per Share (Diluted) (TTM) |
= | 0.89 | / | -0.121 | |
= | At Loss |
Elite Health Systems's share price for today is $0.89.
Elite Health Systems's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.121.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
Please read Which price ratio outperforms the enterprise multiple?
Thank you for viewing the detailed overview of Elite Health Systems's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Lawrence William St | director | 23 ASHLAND STREET, NEWBURYPORT MA 01950-1905 |
William F. Leimkuhler | director | 43 SALEM STRAITS RD, DARIEN CT 06820 |
Merriman Charles H Iii | director | |
Alan Gold | director, 10 percent owner, officer: President & Chairman | 2400 RESEARCH BLVD, SUITE 325, ROCKVILLE MD 20850 |
Stanley S Shuman | 10 percent owner | C/O RIPPLEWOOD HOLDINGS LLC, ONE ROCKERFELLER PLAZA, NEW YORK NY 10020 |
Allen & Co Inc | 10 percent owner | 711 FIFTH AVENUE, NEW YORK NY 10022 |
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.